HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.

AbstractBACKGROUND:
Gastro-oesophageal reflux is common in preterm newborns; at present, no studies have evaluated the efficacy of sodium alginate in this population.
AIM:
To evaluate the effect of sodium alginate on gastro-oesophageal reflux features in preterm newborns by combined pH and impedance monitoring (pH-MII).
METHODS:
Thirty-two symptomatic preterm newborns underwent a 24 h pH-MII, during which each baby was fed eight times. Sodium alginate was given four times at alternate meals [drug-given (DG) vs. drug-free (DF) meals]. Gastro-oesophageal reflux features (i.e. number, acidity, duration and height of gastro-oesophageal reflux) after DG and DF meals were compared by Wilcoxon signed ranks test.
RESULTS:
Sodium alginate significantly decreased the number of acid gastro-oesophageal reflux detected either by pH monitoring (DG vs. DF: median 17.00 vs. 29.00, P = 0.002) and MII (DG vs. DF: 4.0 vs. 6.00, P = 0.050), and also acid oesophageal exposure (DG vs. DF: 4.0% vs. 7.6%, P = 0.030), without any influence on non-acid gastro-oesophageal reflux. Furthermore, it decreased the number of gastro-oesophageal reflux reaching proximal oesophagus (DG vs. DF: 5.50 vs. 7.50, P = 0.030).
CONCLUSIONS:
The use of sodium alginate in preterm infants seems to be promising, because this drug decreases gastro-oesophageal reflux acidity and height with the advantage of a nonsystemic way of action and a more favourable safety profile over H2 blockers and PPIs.
AuthorsL Corvaglia, A Aceti, E Mariani, M De Giorgi, M G Capretti, G Faldella
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 33 Issue 4 Pg. 466-70 (Feb 2011) ISSN: 1365-2036 [Electronic] England
PMID21158879 (Publication Type: Clinical Trial, Journal Article)
Copyright© 2010 Blackwell Publishing Ltd.
Chemical References
  • Alginates
  • Antacids
  • Drug Combinations
  • Silicic Acid
  • Aluminum Hydroxide
  • alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
  • Sodium Bicarbonate
Topics
  • Alginates (therapeutic use)
  • Aluminum Hydroxide (therapeutic use)
  • Antacids (therapeutic use)
  • Drug Combinations
  • Female
  • Gastric Acidity Determination
  • Gastroesophageal Reflux (drug therapy)
  • Humans
  • Hydrogen-Ion Concentration
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (drug therapy)
  • Male
  • Silicic Acid (therapeutic use)
  • Sodium Bicarbonate (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: